Literature DB >> 10456384

Local administration of activin promotes fracture healing in the rat fibula fracture model.

R Sakai1, K Miwa, Y Eto.   

Abstract

Osteogenic activities of activin, a member of the transforming growth factor (TGF)-beta superfamily, have been demonstrated in both in vitro and in vivo studies. The present study investigates the effects of topical application of activin on fracture healing using rat fibula fracture models. Activin (0.4-10 microg/day) was injected locally to the fracture once a day for 2 weeks. Activin promoted callus formation in a dose-dependent manner and both callus volume and callus weight were significantly increased with doses of 2-10 microg/day activin. Also, 3 weeks of activin treatment increased the mechanical strength of the healing bone in addition to the callus mass. Histological study 2 weeks after the fracture revealed that activin promoted endochondral bone formation. Immunohistochemical examination of the fractured tibia revealed that activin was localized to osteoblasts and chondrocytes in the region ossified both endochondrally and intramembranously. These findings suggest that activin expressed during fracture healing promotes the healing process through an autocrine/paracrine mode of action.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10456384     DOI: 10.1016/s8756-3282(99)00152-0

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  15 in total

1.  Growth factors and cytokines in patients with long bone fractures and associated spinal cord injury.

Authors:  Fathy G Khallaf; Elijah O Kehinde; Ahmed Mostafa
Journal:  J Orthop       Date:  2016-02-22

2.  Association of SMAD2 polymorphisms with bone mineral density in postmenopausal Korean women.

Authors:  B-J Kim; J-Y Hwang; B-G Han; J-Y Lee; J Y Lee; E K Park; S H Lee; Y-E Chung; G S Kim; S-Y Kim; J-M Koh
Journal:  Osteoporos Int       Date:  2010-10-30       Impact factor: 4.507

3.  Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass.

Authors:  Brian C Goh; Vandana Singhal; Angelica J Herrera; Ryan E Tomlinson; Soohyun Kim; Marie-Claude Faugere; Emily L Germain-Lee; Thomas L Clemens; Se-Jin Lee; Douglas J DiGirolamo
Journal:  J Biol Chem       Date:  2017-06-28       Impact factor: 5.157

4.  Activin A suppresses interleukin-1-induced matrix metalloproteinase 3 secretion in human chondrosarcoma cells.

Authors:  Deh-Ming Chang; Shao-Hsiang Liu; Herng-Sheng Lee; Jenn-Hung Lai; Chen-Hung Chen
Journal:  Rheumatol Int       Date:  2007-04-14       Impact factor: 2.631

Review 5.  [Biological coating of implants in trauma and orthopedic surgery].

Authors:  M J Raschke; G Schmidmaier
Journal:  Unfallchirurg       Date:  2004-08       Impact factor: 1.000

6.  Myostatin (GDF-8) deficiency increases fracture callus size, Sox-5 expression, and callus bone volume.

Authors:  Ethan Kellum; Harlan Starr; Phonepasong Arounleut; David Immel; Sadanand Fulzele; Karl Wenger; Mark W Hamrick
Journal:  Bone       Date:  2008-09-13       Impact factor: 4.398

7.  Activin A expression regulates multipotency of mesenchymal progenitor cells.

Authors:  Farida Djouad; Wesley M Jackson; Brent E Bobick; Sasa Janjanin; Yingjie Song; George T J Huang; Rocky S Tuan
Journal:  Stem Cell Res Ther       Date:  2010-05-04       Impact factor: 6.832

Review 8.  Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, Activin and Inhibin.

Authors:  Kristy M Nicks; Daniel S Perrien; Nisreen S Akel; Larry J Suva; Dana Gaddy
Journal:  Mol Cell Endocrinol       Date:  2009-07-15       Impact factor: 4.102

9.  A soluble activin type IIA receptor induces bone formation and improves skeletal integrity.

Authors:  R Scott Pearsall; Ernesto Canalis; Milton Cornwall-Brady; Kathryn W Underwood; Brendan Haigis; Jeffrey Ucran; Ravindra Kumar; Eileen Pobre; Asya Grinberg; Eric D Werner; Vaida Glatt; Lisa Stadmeyer; Deanna Smith; Jasbir Seehra; Mary L Bouxsein
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-06       Impact factor: 11.205

10.  A novel low-molecular-weight compound enhances ectopic bone formation and fracture repair.

Authors:  Eugene Wong; Sreedhara Sangadala; Scott D Boden; Katsuhito Yoshioka; William C Hutton; Colleen Oliver; Louisa Titus
Journal:  J Bone Joint Surg Am       Date:  2013-03-06       Impact factor: 5.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.